PUMA BIOTECHNOLOGY, INC. Capital Expenditures Incurred but Not yet Paid
PUMA BIOTECHNOLOGY, INC. (PBYI) reported Capital Expenditures Incurred but Not yet Paid of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-06
- PUMA BIOTECHNOLOGY, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was $5.00K.
- PUMA BIOTECHNOLOGY, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was -$10.00K, a 200.00% decline year-over-year.
- PUMA BIOTECHNOLOGY, INC. capital expenditures incurred but not yet paid for the quarter ending 2024-12-31 was -$20.00K, a 176.92% decline year-over-year.
- PUMA BIOTECHNOLOGY, INC. capital expenditures incurred but not yet paid for the quarter ending 2024-09-30 was $10.00K.
- PUMA BIOTECHNOLOGY, INC. capital expenditures incurred but not yet paid for fiscal 2025 was $5.00K.
- PUMA BIOTECHNOLOGY, INC. capital expenditures incurred but not yet paid for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- PUMA BIOTECHNOLOGY, INC. capital expenditures incurred but not yet paid for fiscal 2023 was $26.00K.
- PUMA BIOTECHNOLOGY, INC. capital expenditures incurred but not yet paid for fiscal 2022 was $0.00.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 | |||
| 2025-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$5.00K derived: sum of 2 quarters · filed 2026-02-26 | $5.00K 10-K · filed 2026-02-26 | |
| 2025-09-30 | -$10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | $10.00K 10-Q · filed 2026-08-06 | |||
| 2024-12-31 | -$20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$10.00K derived: sum of 2 quarters · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 | |
| 2024-09-30 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $20.00K 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | $10.00K 10-Q · filed 2025-08-07 | |||
| 2023-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $11.00K derived: sum of 2 quarters · filed 2026-02-26 | $26.00K 10-K · filed 2026-02-26 | |
| 2023-09-30 | -$15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | ||
| 2023-06-30 | $15.00K 10-Q · filed 2024-08-01 | |||
| 2022-12-31 | -$7.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $0.00 10-K · filed 2025-02-27 | |
| 2022-09-30 | $7.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $7.00M 10-Q · filed 2023-11-02 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-03 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-29 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-03-03 | |||
| 2020-03-31 | $13.00K 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | $25.00K 10-K · filed 2022-03-03 | |||
| 2018-09-30 | -$91.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$26.00K derived: sum of 2 quarters · filed 2019-11-07 | $59.00K 10-Q · filed 2019-11-07 | -$19.00K derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | $65.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $150.00K 10-Q · filed 2019-08-09 | $72.00K derived: sum of 3 quarters · filed 2020-02-28 | $23.00K derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $85.00K 10-Q · filed 2019-05-10 | $7.00K derived: sum of 2 quarters · filed 2020-02-28 | -$42.00K derived: sum of 3 quarters · filed 2020-02-28 | |
| 2017-12-31 | -$78.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | -$127.00K derived: sum of 2 quarters · filed 2020-02-28 | $27.00K 10-K · filed 2020-02-28 | |
| 2017-09-30 | -$49.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $105.00K 10-Q · filed 2018-11-05 | ||
| 2017-06-30 | $154.00K 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |